P2X7 receptor as the regulator of T-cell function in intestinal barrier disruption
- PMID: 36185635
- PMCID: PMC9521516
- DOI: 10.3748/wjg.v28.i36.5265
P2X7 receptor as the regulator of T-cell function in intestinal barrier disruption
Abstract
The intestinal mucosa is a highly compartmentalized structure that forms a direct barrier between the host intestine and the environment, and its dysfunction could result in a serious disease. As T cells, which are important components of the mucosal immune system, interact with gut microbiota and maintain intestinal homeostasis, they may be involved in the process of intestinal barrier dysfunction. P2X7 receptor (P2X7R), a member of the P2X receptors family, mediates the effects of extracellular adenosine triphosphate and is expressed by most innate or adaptive immune cells, including T cells. Current evidence has demonstrated that P2X7R is involved in inflammation and mediates the survival and differentiation of T lymphocytes, indicating its potential role in the regulation of T cell function. In this review, we summarize the available research about the regulatory role and mechanism of P2X7R on the intestinal mucosa-derived T cells in the setting of intestinal barrier dysfunction.
Keywords: Intestinal barrier dysfunction; P2X7 receptor; T lymphocyte.
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Figures




Similar articles
-
Persistent Activation of the P2X7 Receptor Underlies Chronic Inflammation and Carcinogenic Changes in the Intestine.Int J Mol Sci. 2024 Oct 10;25(20):10874. doi: 10.3390/ijms252010874. Int J Mol Sci. 2024. PMID: 39456655 Free PMC article. Review.
-
Systemic blockade of P2X7 receptor protects against sepsis-induced intestinal barrier disruption.Sci Rep. 2017 Jun 29;7(1):4364. doi: 10.1038/s41598-017-04231-5. Sci Rep. 2017. PMID: 28663567 Free PMC article.
-
The P2X7 Receptor in Infection and Inflammation.Immunity. 2017 Jul 18;47(1):15-31. doi: 10.1016/j.immuni.2017.06.020. Immunity. 2017. PMID: 28723547 Review.
-
Purinergic P2X7 receptor blockade mitigates alcohol-induced steatohepatitis and intestinal injury by regulating MEK1/2-ERK1/2 signaling and egr-1 activity.Int Immunopharmacol. 2019 Jan;66:52-61. doi: 10.1016/j.intimp.2018.11.012. Epub 2018 Nov 13. Int Immunopharmacol. 2019. PMID: 30445307
-
Purinergic P2X7 Receptor Mediates the Elimination of Trichinella spiralis by Activating NF-κB/NLRP3/IL-1β Pathway in Macrophages.Infect Immun. 2021 Apr 16;89(5):e00683-20. doi: 10.1128/IAI.00683-20. Print 2021 Apr 16. Infect Immun. 2021. PMID: 33558327 Free PMC article.
Cited by
-
Pharmacology of P2X Receptors and Their Possible Therapeutic Potential in Obesity and Diabetes.Pharmaceuticals (Basel). 2024 Sep 28;17(10):1291. doi: 10.3390/ph17101291. Pharmaceuticals (Basel). 2024. PMID: 39458933 Free PMC article. Review.
-
Role of the P2X7 receptor in breast cancer progression.Purinergic Signal. 2024 Jul 23. doi: 10.1007/s11302-024-10039-6. Online ahead of print. Purinergic Signal. 2024. PMID: 39039304 Review.
-
Persistent Activation of the P2X7 Receptor Underlies Chronic Inflammation and Carcinogenic Changes in the Intestine.Int J Mol Sci. 2024 Oct 10;25(20):10874. doi: 10.3390/ijms252010874. Int J Mol Sci. 2024. PMID: 39456655 Free PMC article. Review.
-
Administration of an AAV vector coding for a P2X7-blocking nanobody-based biologic ameliorates colitis in mice.J Nanobiotechnology. 2024 Jan 11;22(1):27. doi: 10.1186/s12951-023-02285-4. J Nanobiotechnology. 2024. PMID: 38212782 Free PMC article.
-
Gut redox and microbiome: charting the roadmap to T-cell regulation.Front Immunol. 2024 Aug 21;15:1387903. doi: 10.3389/fimmu.2024.1387903. eCollection 2024. Front Immunol. 2024. PMID: 39234241 Free PMC article. Review.
References
-
- Salvo Romero E, Alonso Cotoner C, Pardo Camacho C, Casado Bedmar M, Vicario M. The intestinal barrier function and its involvement in digestive disease. Rev Esp Enferm Dig. 2015;107:686–696. - PubMed
-
- Huang Z, Weng Y, Shen Q, Zhao Y, Jin Y. Microplastic: A potential threat to human and animal health by interfering with the intestinal barrier function and changing the intestinal microenvironment. Sci Total Environ. 2021;785:147365. - PubMed
-
- Cui Y, Wang Q, Chang R, Zhou X, Xu C. Intestinal Barrier Function-Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota. J Agric Food Chem. 2019;67:2754–2762. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials